Results 21 to 30 of about 298,000 (263)

Level of physicians’ awareness of epidemiology, outcomes, prevention and treatment of chronic hepatitis B and C [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2018
Objective. To evaluate a level of physicians’ awareness of the specific issues of epidemiology, outcomes, prevention and treatment of chronic hepatitis B and C. Materials and Methods.
Baramzina S.V.
doaj   +1 more source

Costs of Treatment, Follow-Up, and Complications of Chronic Hepatitis B and Hepatitis C Infections

open access: yesBalkan Medical Journal, 2013
Background: Few studies have addressed the indirect costs of chronic hepatitis B and C, and none has assessed the real costs of these conditions, including indirect costs caused by loss of work, in Turkey. Aims: This study therefore analysed the costs of
Fatma Banu Karahasanoğlu   +3 more
doaj   +1 more source

Endothelial activation markers (VCAM-1, vWF) in patients with chronic hepatitis C and insulin resistance

open access: yesЖурнал инфектологии, 2014
Blood markers of endothelial activation (sVCAM-1, vWF: Ag) in patients with chronic hepatitis C in the presence of insulin resistance, metabolic syndrome and its components had been evaluated.
T. V. Antonova   +2 more
doaj   +1 more source

Hepatitis C prevalence in Denmark -an estimate based on multiple national registers

open access: yesBMC Infectious Diseases, 2012
Background A national survey for chronic hepatitis C has not been performed in Denmark and the prevalence is unknown. Our aim was to estimate the prevalence of chronic hepatitis C from public registers and the proportion of these patients who received ...
Christensen Peer   +8 more
doaj   +1 more source

Eltrombopag in chronic hepatitis C

open access: yesWorld Journal of Gastroenterology, 2014
Chronic hepatitis C is a public health problem worldwide. Unfortunately, not all patients may benefit from antiviral therapy due to thrombocytopenia. Its causes are represented by portal hypertension and platelet sequestration in the spleen, decreased serum levels or activity of thrombopoietin, the bone marrow suppression induced by hepatitis C virus ...
Romeo-Gabriel, Mihăilă   +1 more
openaire   +2 more sources

Metastatic niche shaped by host factors influences disseminated cancer cell fate

open access: yesFEBS Letters, EarlyView.
Metastasis is shaped not only by cancer cells but also by the environments they encounter. This review explores how factors such as aging, diet, the microbiome, lifestyle, and environmental exposures remodel organ‐specific niches in the lung, liver, bone, and brain, influencing where metastatic cells survive, remain dormant, or grow, and ultimately ...
Gwennan Delyth Ward   +2 more
wiley   +1 more source

Neutralization of the PTX3/CD44 axis suppresses TGF‐β1 signaling in kidney fibrosis

open access: yesFEBS Letters, EarlyView.
This study investigates how the PTX3/CD44 axis promotes kidney fibrosis by activating TGF‐β1 signaling. We demonstrate that the neutralizing antibody WHC‐001 effectively inhibits this pathway, suppressing myofibroblast activation and partial epithelial–mesenchymal transition (EMT).
Chao‐Chun Cheng   +8 more
wiley   +1 more source

REGIONAL PATTERNS OF THE SPREAD OF HEPATITIS B AND C AMID THE COVID-19 PANDEMIC AND FULL-SCALE WAR: 2019–2025

open access: yesПроблеми екології та медицини
Introduction. The incidence of viral hepatitis B and C in Ukraine has undergone significant changes and a geographical redistribution in recent years against the backdrop of the COVID-19 pandemic and a full-scale war, both of which have significantly ...
O.G. Marchenko   +11 more
doaj   +1 more source

Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy

open access: yesFEBS Letters, EarlyView.
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley   +1 more source

The influence of hepatic steatosis on the success of antiviral therapy for chronic hepatitis C [PDF]

open access: yesVojnosanitetski Pregled, 2017
Background/Aim. Chronic hepatitis C and liver steatosis often appear simultaneously in the same person, and steatosis can lead to worsening of liver disease and reducing the success of the treatment of chronic hepatitis C.
Preveden Tomislav   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy